FDA Leadership

Several Candidates are Contending for the Top FDA Job

Nice Insight

Bacteria Engineering

A Triplex Approach to Bacteria Engineering

Emilie Branch

Pharma's Almanac

Data Integrity

Novartis Pledges 5-Day Response Regarding Future Data Integrity Issues

Nice Insight

Patient Centricity

Astellas Takes Patient Centricity to the Next Level

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Epigenetics

Turning Back the Epigenetic Clock?

Emilie Branch

Pharma's Almanac

Drug Pricing

FDA CDER Head Castigates Pharma Industry

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Leadership

Cerevel Gets New CEO

Nice Insight

Clinical Trial

Arial Halts Trial for First Drug to Treat DRP Early

Nice Insight

Genfit Gets New CEO as it Moves to Approval and Commercialization Stage

David Alvaro, Ph.D.

Pharma's Almanac

Movement in Cases Against Pharma Regarding the Opioid Crisis

Nice Insight

Healthcare Ads Are Going Digital

Emilie Branch

Pharma's Almanac

FDA Clearance

New Vision System for Tracking Eye Movement Gets FDA Clearance

Nice Insight

Device

SUNY Researchers Developing Device to Restore Vision to AMD Sufferers

David Alvaro, Ph.D.

Pharma's Almanac

Prevention

Could Preventing the Development of Amyloid Beta Lesions in the Brain Stop Alzheimer’s?

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Safety Warning

Patient Deaths Lead to FDA Safety Warning on Hepatitis C Medication

Nice Insight

Competition

Current Players Could Face Competition in the PCSK9 Space

Nice Insight

M&A

Zhejiang Jiuzhou to Acquire Suzhou Unit of Novartis AG for CNY790 Million

Nice Insight

CRISPR

Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain

Emilie Branch

Pharma's Almanac

Depression

Trump Urges VA to Use Spravato

Nice Insight

Anxiety

Studies in Primates Reveal Potential New Target for Anxiety Treatments

Cynthia A. Challener, Ph.D.

Pharma's Almanac